Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Investigator-initiated health-related quality-of-life-research

Go back to Resources

Investigator-initiated health-related quality-of-life-research

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Initial immunosuppression with Mycophenolate or Tacrolimus is not associated with increased risk for post-transplant lymphoproliferative disorder: a North American Pediatric Cooperative Study (NAPRTCS) Report

Go back to Resources

Initial immunosuppression with Mycophenolate or Tacrolimus is not associated with increased risk for post-transplant lymphoproliferative disorder: a North American Pediatric Cooperative Study (NAPRTCS) Report

Authors:

Location:

Go back to Resources

Incorporating a cognitive function ancillary study in an ophthalmic clinical trial

Go back to Resources

Incorporating a cognitive function ancillary study in an ophthalmic clinical trial

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Horizontal rectus tenotomy in the treatment of Congenital Nystagmus (CN)

Go back to Resources

Horizontal rectus tenotomy in the treatment of Congenital Nystagmus (CN)

Authors:

Location:

Go back to Resources

After six thousand transplants where are we? The state of pediatric renal transplantation in North America

Go back to Resources

After six thousand transplants where are we? The state of pediatric renal transplantation in North America

Authors:

Location:

Go back to Resources

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss: AREDS Report No. 9

Go back to Resources

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss: AREDS Report No. 9

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

A randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation

Go back to Resources

A randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation

Authors:

Location:

Go back to Resources

A Phase II study of two HIV-1 envelope vaccines comparing their immunogenicity in populations at risk for acquiring HIV-1 infection

Go back to Resources

A Phase II study of two HIV-1 envelope vaccines comparing their immunogenicity in populations at risk for acquiring HIV-1 infection

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

A Freedom of Information Act tale

Go back to Resources

A Freedom of Information Act tale

Authors:

Location:

Go back to Resources

Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes

Go back to Resources

Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 142
  • Page 143
  • Page 144
  • Page 145
  • Current page 146
  • Page 147
  • Page 148
  • Page 149
  • Page 150
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification